Serum complement C3c concentration in non-obese young insulin-resistant Mexicans

Diabetes, Nutrition and Metabolism - Clinical and Experimental

Volumn 15, Issue 4, 2002, Pages 256-259

  Gonzalez Ortiz M ^a   Martinez Abundis E ^a   Grover Paez F ^a   Pascoe Gonzalez S ^a  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

Author keywords

C3 concentrations; Insulin resistance; Insulin sensitivity; Obesity

Indexed keywords

COMPLEMENT COMPONENT C3C; GLUCOSE; INSULIN; LIPID; URIC ACID;

ADULT; ARTICLE; BLOOD LEVEL; BODY MASS; CHEMICAL ANALYSIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC KIT; ENZYME ASSAY; ETHNIC GROUP; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULIN TOLERANCE TEST; LIPID ANALYSIS; MALE; MEXICO; NEPHELOMETRY; PRIORITY JOURNAL; VOLUNTEER;

ADULT; BLOOD GLUCOSE; BODY MASS INDEX; COMPLEMENT C3C; CROSS-SECTIONAL STUDIES; HUMANS; INSULIN; INSULIN RESISTANCE; KINETICS; LIPIDS; MALE; MEXICO; NEPHELOMETRY AND TURBIDIMETRY; URIC ACID;

EID: 0036700684     PISSN: 03943402     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Fearon D.T., Locksley R.M.: The instructive role of innate immunity in the acquired immune response. Science 2: 50-54, 1996.
2. Figueredo A., Ibarra J.L., Bagazgoitia J., Rodríguez A., Molino A.M., Fernandez-Cruz A., Patino R.: Plasma C3d levels and ischemic heart disease in type II diabetes. Diabetes Care 16: 445-449, 1993.
3. Mantov S., Raev D.: Additive effects of diabetes and systemic hypertension on the immune mechanisms of atherosclerosis. Int. J. Cardiol. 56: 145-148, 1996.
4. Ylitalo K., Porkka K.V.K., Meri S., Nuotio I., Suurinkeroinen L, Vakkilainen J., Pajukanta P., Viikari J.S.A., Peltonen L., Ehnholm C., Taskinen M.R.: Serum complement and familial combined hyperlipidemia. Atherosclerosis 129: 271-277, 1997.
5. Weyer C.H., Tataranni P.A., Pratley R.E.: Insulin action and insulinemia are closely related to the fasting complement C3, but not acylation stimulating protein concentration. Diabetes Care 23: 779-785, 2000.
6. González-Ortiz M., Martínez-Abundis E., Escalante-Pulido J.M.: Comparison of homeostasis model analysis with insulin tolerance test in the assessment of insulin resistance in healthy young people. Diab. Nutr. Metab. 11: 136-139, 1998.
7. Muscari A., Massarelli G., Bastagli L., Poggiopollini G., Tomassetti V., Drago G., Martignani C., Pacilli P., Boni P., Puddu P.: Relationship of serum C3 to fasting insulin, risk factors and previous ischaemic events in middle-aged men. Eur. Heart J. 21: 1081-1090, 2000.
8. Pomeroy C., Mitchell J., Eckert E., Raymond N., Crosby R., Dalmasso AP.: Effect of body weight and caloric restriction on plasma complement proteins, including factor D/adipsin: studies in anorexia nervosa and obesity. Clin. Exp. Immunol. 108: 507-515, 1997.
9. Choy L.N., Rosen B.S., Spiegelman B.M.: Adipsin and an endogenous pathway of complement from adipose cells. J. Biol. Chem. 267: 12736-12741, 1992.
10. Pickup J.C., Crook M.A.: Is type 2 diabetes mellitus a disease of the innate immune system? Diabetologia 41: 1241-1248, 1998.
11. De Fronzo R.A., Ferrannini E.: Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14: 173-194, 1991.
12. Maslowska M.H., Sniderman A.D., Germinario R., Cianflone K.: ASP stimulates glucose transport in cultured human adipocytes. Int. J. Obes. 21: 261-266, 1997.
13. Muscari A., Massarelli G., Bastagli L., Poggiopollini G., Tomassetti V., Volta U., Puddu G.M., Puddu P.: Relationship between serum C3 levels and traditional risk factors for myocardial infarction. Acta Cardiol. 53: 345-354, 1998.